About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
2020 ASCO Virtual Direct™ Highlights
Boston
Breast
GYN
Lung
GI
GU
Skin
Hematologic Oncology
Head&Neck
Supportive/Palliative Care
St. Louis
Breast
GYN
Lung
GI
GU
Skin
Hematologic Oncology
Head&Neck
Supportive/Palliative Care
Basic Science
Jacksonville
Breast
Hematologic Oncology
Lung
GI
GU
GYN
Skin
Head&Neck
Basic Science
Philadelphia
GI
GU
Lung
Skin
Hematologic Oncology
Breast
Supportive/Palliative Care
Head&Neck
GYN
Denver
Breast
Hematologic Oncology
Lung
GU
Skin
GYN
Head&Neck
Basic Science
San Francisco
Breast
Lung
GU
Hematologic Oncology
Skin
GI
GYN
Head&Neck
Business
Las Vegas
GI
GU
Hematologic Oncology
Skin
Lung
Head&Neck
GYN
Business
San Juan
Breast
GI
Hematologic Oncology
Skin
GYN
Basic Science
Head and Neck
Supportive and Palliative Care
Business
Events
GI
11:33
2020 ASCO Virtual Direct™ Highlights
2020 ASCO Update on Locoregional CRC: 3 vs. 6 Months of Adjuvant Oxaliplatin + Fluoropyrimidine - Is There a Difference in 5 yr OS?
FEATURING
Louise Connell
395 views
July 14, 2020
2
09:21
2020 ASCO Virtual Direct™ Highlights
2020 ASCO Update on Advanced CRC: Should Pembrolizumab Be The New SoC as First-line Therapy in Patients With MSI-H mCRC?
FEATURING
Louise Connell
499 views
July 14, 2020
2
14:43
2020 ASCO Virtual Direct™ Highlights
2020 ASCO Update on Advanced CRC: Is Recently FDA Approved Encorafenib + Cetuximab a New SoC for Previously Treated BRAF V600E-mutant mCRC? Can T-DXd Be an Option for HER2+ Disease?
FEATURING
Louise Connell
190 views
July 14, 2020
1
12:38
2020 ASCO Virtual Direct™ Highlights
2020 ASCO Pancreatic Cancer Update: Does Gemcitabine + Nab-paclitaxel Improve Complete Pathologic Response in Resectable Disease?
FEATURING
Caio Rocha Lima
257 views
July 14, 2020
1
08:03
2020 ASCO Virtual Direct™ Highlights
2020 ASCO HCC Update: Is Tremelimumab + Durvalumab Effective, Tolerable, and Biologically Active in Advanced Disease?
FEATURING
Caio Rocha Lima
112 views
July 14, 2020
11:08
2020 ASCO Virtual Direct™ Highlights
2020 ASCO Update on Gastric & Esophageal: Does the Addition of Pertuzumab/Trastuzumab to FLOT Improve PCR? Can Ramucirumab + FLOT Improve R0 Resection?
FEATURING
Caio Rocha Lima
144 views
July 14, 2020
1
